NASDAQ: BOLD
Boundless Bio Inc Stock Ownership - Who owns Boundless Bio?

Insider buying vs selling

Have Boundless Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BOLD insiders and whales buy or sell their stock.

BOLD Shareholders

What type of owners hold Boundless Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Nuveen LLC17.68%3,958,413$4.71MInstitution
Fmr LLC14.11%3,157,772$3.76MInstitution
Ra Capital Management LP9.74%2,180,631$2.59MInstitution
Nextech Invest Ltd5.49%1,228,069$1.46MInstitution
Kristina Burow5.28%1,181,766$1.41MInsider
Keith Crandell5.28%1,181,766$1.41MInsider
Arch Venture Fund IX LP5.28%1,181,766$1.41MInsider
Citadel Advisors LLC3.71%830,936$988.81kInstitution
Redmile Group LLC3.24%725,204$862.99kInstitution
Sectoral Asset Management Inc3.03%678,574$807.50kInstitution

1 of 3

BOLD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BOLD75.81%23.82%
RADX0.02%0.00%
GBIO60.72%39.28%Net BuyingNet Selling
ALXO65.13%27.88%Net BuyingNet Selling
TPST10.61%89.39%Net Selling

Boundless Bio Stock Ownership FAQ

Who owns Boundless Bio?

Boundless Bio (NASDAQ: BOLD) is owned by 75.81% institutional shareholders, 23.82% Boundless Bio insiders, and 0.36% retail investors. Kristina Burow is the largest individual Boundless Bio shareholder, owning 1.18M shares representing 5.28% of the company. Kristina Burow's Boundless Bio shares are currently valued at $1.41M.

If you're new to stock investing, here's how to buy Boundless Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.